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Background: Transcranial direct current stimulation (tDCS) has been investigated mainly in
adults and doses may not be appropriate in pediatric applications. In perinatal stroke where
potential applications are promising, rational adaptation of dosage for children remains
under investigation.
Objective: Construct child-specific tDCS dosing parameters through case study within a
perinatal stroke tDCS safety and feasibility trial.
Methods: 10-year-old subject with a diagnosis of presumed perinatal ischemic stroke and
hemiparesis was identified. T1 magnetic resonance imaging (MRI) scans used to derive
computerized model for current flow and electrode positions. Workflow using modeling
results and consideration of dosage in previous clinical trials was incorporated. Prior ad hoc
adult montages vs. de novo optimized montages provided distinct risk benefit analysis.
Approximating adult dose required consideration of changes in both peak brain current
flow and distribution which further tradeoff between maximizing efficacy and adding safety
factors. Electrode size, position, current intensity, compliance voltage, and duration were
controlled independently in this process.
Results: Brain electric fields modeled and compared to values previously predicted models
(Datta et al., 2011; Minhas et al., 2012). Approximating conservative brain current flow
patterns and intensities used in previous adult trials for comparable indications, the
optimal current intensity established was 0.7 mA for 10 min with a tDCS C3/C4 montage.
Specifically 0.7 mA produced comparable peak brain current intensity of an average adult
receiving 1.0 mA. Electrode size of 5 × 7 cm2 with 1.0 mA and low-voltage tDCS was
employed to maximize tolerability. Safety and feasibility confirmed with subject tolerating
the session well and no serious adverse events.
Conclusion: Rational approaches to dose customization, with steps informed by
computational modeling, may improve guidance for pediatric stroke tDCS trials.
Keywords: pediatrics, stroke, hemiparesis, modeling, transcranial direct current stimulation
INTRODUCTION
Transcranial direct current stimulation (tDCS) modulates human
cortical excitability and improved motor outcomes in adults
with and without neurologic diagnoses (Brunoni et al., 2012).
For reasons of safety, cost, portability and potential promise for
improved outcomes in children, we desired to investigate the
application of tDCS in pediatric stroke. Considering the potential
variability in dosing for the child’s brain, due to difference in brain
size and anatomy, the direct transition from adult dosing to the
safe and effective dose in a child has not yet been established.
The relationship between the dose of stimulation (defined as
the externally controlled parameters) (Peterchev et al., 2012) and
brain current flow can be complex, such that computational
models are used in dose design (Bikson et al., 2012). While for
adults there are generally adopted principles regarding directions
of effect (anodal excites, cathodal inhibits) and dosing (10–20
min, 0.5–2.0 mA), emerging evidence suggests even minor dose or
brain integrity changes can lead to opposite effects (Fritsch et al.,
2010; Fricke et al., 2011; Sohn et al., 2012; Batsikadze et al., 2013;
Hasan et al., 2013; Schabrun et al., 2013). Moreover, modeling and
imaging studies suggest limitations in the conventional effects of
anodal and cathodal stimulation (Datta et al., 2009; Antal et al.,
2012, 2014; Peña Gómez et al., 2012; Wagner et al., 2012; Rahman
et al., 2013).
In contrast to individual-specific cortical excitability testing
using TMS, subject-specific titration of dose in tDCS is rare,
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though probably equally important. When working with chil-
dren, (even when adopting a technique such as tDCS, with a
compelling safety record in adults) questions of safety gain new
importance. Subject specific factors such as differences in brain
size, water content, myelination, proximity of the brain to the
skull and other characteristics of the developing brain may alter
safety/tolerability and optimal dose (Minhas et al., 2012; Kessler
et al., 2013). A broad review of available clinical reports integrated
with computational models provides a basis to address this issue.
This report describes the methods used in consideration of a pilot
safety study applying a single-session of tDCS in a child with
hemiparesis due to perinatal stroke and more broadly presents
possible methodology for dose customization in pediatric pop-
ulations (clinicaltrials.gov NCT01636661). A child who met the
inclusion criteria for the pilot was identified, and the following
methods were employed to establish safety and feasibility of the
application of tDCS before the trial began. The description below
identifies the methods in detail, while the trial itself is reported
elsewhere (Gillick et al., in press). The study was approved by
the University of Minnesota Institutional Review Board, and the
Clinical and Translational Science Institute, Written and verbal
parental consent and child assent was obtained. Modeling analysis
of de-identified data at City College of New York of CUNY is IRB
exempt.
COMPONENTS OF TRIAL DESIGN
At this time, a standardized tDCS dose has not been estab-
lished, neither in adults or children. Understanding this, in order
to determine tDCS parameters for this subject, we reviewed
existing clinical experience and publications regarding current
parameters of tDCS dose (including current polarity and inten-
sity) from healthy adults and adults with stroke. Computational
models were used to relate brain current flow in these cases to
that in a child with stroke and resultant hemiparesis. Broadly,
the goal was to use a stimulation paradigm that (1) produced
the same brain current intensity (not necessarily same external
dose) as in the adult cortex; and (2) targeted the motor cor-
tices of the brain and the interactions between the hemispheres.
However, a detailed methodological analysis, driven by rational
trial design, and divergent approaches toward this aim must be
selected balancing tradeoffs between innovation/conservatism,
efficacy/safety, and putative non-monotonic dose response. Our
process involved seven specific steps from concept to implementa-
tion: (1) gathering of subject-specific information; (2) formulat-
ing the desired clinical outcome; (3) considering constraints that
may influence decisions; (4) defining brain current flow criterion;
(5) investigating potential montages; (6) modeling montages to
estimate brain current flow; and (7) determination of subject-
specific dose. These stages are elaborated below and summarized
in Figure 1.
SUBJECT-SPECIFIC INFORMATION
This pilot study focused on a 10-year-old child with a diagnosis
of arterial perinatal ischemic stroke. The child had a normal
perinatal history but presented in infancy with hemiparesis and
was found to have a focal infarction (Kirton, 2013). Magnetic
resonance imaging (MRI) confirmed a distal M1 segment of the
middle cerebral artery stroke with involvement of peri-Rolandic
regions of the right frontal and parietal lobes and centrum semio-
vale but sparing of the basal ganglia. Left hemiparesis was first
noted at 4 months of age. At 10 years, the child had moderate
hemiparetic cerebral palsy with a Manual Ability Classification
System Scale Score (Eliasson et al., 2006, 2007) of II—“Handles
Most Objects but with Somewhat Reduced Quality and/or Speed
of Achievement”. The lower extremity was less affected, spasticity
was minimal, and she had not received any new rehabilitation
treatments within 6 months. She was otherwise developmentally
normal, did not have epilepsy, and was not taking any neuroactive
medications. Informed consent was obtained as part of a pilot
safety and feasibility study on the application of tDCS in chil-
dren with congenital hemiparesis (ClinicalTrials.gov Identifier:
NCT01636661).
DESIRED CLINICAL OUTCOME
Emerging evidence combining animal and human studies has
defined models of developmental motor plasticity following
perinatal stroke. These models suggest that inhibition of the
non-lesioned hemisphere might enhance motor learning in the
lesioned hemisphere, possibly via effects on excessive ipsilateral
projections or disordered interhemispheric inhibition. Therefore,
while the underlying neurophysiology is likely different, the strat-
egy in adult stroke of inhibiting the non-lesioned hemisphere with
non-invasive stimulation to enhance therapy may be applicable
to children with perinatal stroke-induced hemiparesis (Hsu et al.,
2012; Marquez et al., 2013). Studies in non-invasive brain stimula-
tion and specifically in the use of repetitive transcranial magnetic
stimulation (rTMS) have recently shown promising results in
children with stroke, requiring further research to determine
further clinical merit in this population (Kirton et al., 2008, 2010;
Gillick et al., 2013).
CONSTRAINTS
DOSE
Given the volume of safety/efficacy data using a limited set of
standard montages (Nitsche and Paulus, 2000; Brunoni et al.,
2012), and because incremental changes may allow precise detec-
tion of potential adverse events, a historical approach of previous
research and modeling was deemed appropriate. To ensure safety
and to decrease the likelihood of side effects, adult protocols
have typically utilized 0.2–2.0 mA with duration of stimulus
≤30 min (Rothwell, 2012; Batsikadze et al., 2013). However, we
propose that when initiating studies in novel, potentially vulner-
able populations (such as children) and/or injured brain (such
as following stroke) approaches in adults should be re-examined
using the latest available tools and scientific data to adjust for
developmental variation in children. Furthermore, identification
of possible risks and risk mitigation were identified (Table 1).
DEVICE
We used a Soterix Limited Total Energy (LTE) 1×1 tDCS unit
which is limited to maximal current of 1.5 mA and 20 min
maximum duration of stimulation. For this specific modeling,
we first determined our current needs, and then the device
model. The LTE also has a built-in sham stimulation mode,
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FIGURE 1 | Conceptual methodology for determination of dose.
Theoretical 7-step compartmentalization of decision workflow (left
column) and implementation considerations specific to this case
study of a 10 year-old child with hemiparesis due to perinatal
stroke (right column). Incorporation of prior experience
in the dose decision process coupled with modeling allows
value-determination of subject-specific dose decisions for
implementation.
providing ramp-up and ramp-down stimulation at the beginning
and end of the placebo session. During the 30–60 s period of
time, the current is increased in order to reach the targeted dose
and then discontinued. Two additional features reinforce safety.
(1) An adaptive impedance monitoring feature provides contin-
uous visual indication of electrode quality before and during
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stimulation. If impedance increases, producing a typical high volt-
age, the device not only automatically reduces the current output
in accordance with changes in resistance but also provides an
alert; and (2) a current monitoring feature acts as an independent
current meter and provides continuous visual indication of the
instant output of the device. This component adds redundancy
to the safety of device and confirms the current setting. Pediatric
size EasyStraps were used to ensure proper contact with the skin
for each individual. Tolerability was enhanced by the RELAX fea-
ture which allows, if enhanced discomfort is expressed, transient
reduction in current without interrupting or aborting the trial.
Once comfort is re-established, the current may then again be
adjusted. The device is limited to two electrodes and used with
5 × 7 EasyPads providing further dose design constraints (i.e.,
number of electrodes, electrode size and maximum current).
CURRENT FLOW CRITERION
Transcranial direct current stimulation alters brain function by
polarizing the brain (Nitsche et al., 2008; Rothwell, 2012). Gen-
erally, brain regions exposed to higher current densities would
be more likely to be influenced and each brain region receives
various current intensity depending on the electrode montage. It
is precisely because brain current flow is not a simple function
of electrode montage (e.g., current is not restricted to only under
the electrodes) that current flow criterion is described in terms
of brain targets for neuromodulation, rather than scalp electrode
position. Moreover, the intensity of current reaching the brain for
any given applied electrode current can vary significantly depend-
ing on the montage and subject anatomy. Thus while electrode
dose is controlled at the head surface (current in mA provided
and montage), current flow criterion indicates the desired current
intensity at the brain target level (in terms of electric field in units
of V/m or A/m2).
With limited research in children, we recognized the need to
re-examine adult-based practices including the effects of relatively
high dose stimulation in adults. In deciding on desired brain
electric field intensity it is typical to reference “gold-standard”
experimentation where modulation of Transcranial Magnetic
Stimulation (TMS)-motor evoked potentials (MEPs) by tDCS was
quantified—with the strong caveat that TMS-MEP modulation
and behavioral changes are only putatively linked. The M1-
S0 montage conventionally used in these studies is shown to
produce lasting TMS-MEP changes following several minutes of
stimulation and with polarity-specific changes at intensities at
1 mA (Nitsche and Paulus, 2000)—where 1 mA corresponds to
approximately 0.3 V/m of electric field in motor regions in adults
(Datta et al., 2012).
Importantly, recent findings suggest that increasing tDCS cur-
rent intensity may change the direction of these effects (Batsikadze
et al., 2013). For example, in a study of 21 healthy adults, 2.0
mA cathodal (0.6 V/m brain electric field) tDCS for a duration
of 20 min over the motor cortex resulted in enhancement of
cortical excitability, not inhibition. An ongoing investigation of
the application of tDCS in children and adolescents ages 10–18
reports that 1 mA anodal and cathodal stimulation over the motor
cortex both produced an increase in the amplitude of the MEPs
(Moliadze et al., 2013) which may reflect the higher brain current
densities (e.g.,∼0.6 V/m) produced in children for the same total
current (see Section Modeling below).
Though non-linear (non-monotonic) TMS-MEP dose
response is observed at higher tDCS intensities, at least across
“moderate” tDCS stimulation intensities response seems
consistent, at least for healthy inactive motor cortex. A study of 14
healthy adults investigated anodal tDCS over the motor cortex for
10 min at three different intensities—0.8, 1.0 and 1.2 mA—and
found no difference in modulation of cortical excitability or
inhibition (Kidgell et al., 2013a). One can therefore speculate
that approximately 0.3 V/m for several minutes is a reasonable
approach. Changes are polarity dependent, with anode/cathode
tending to produce increased/decreased TMS-MEP amplitude,
respectively. Importantly, increasing intensity or duration does
not necessary magnify effects and the direction of changes can
reverse (e.g., 2 mA cathodal is excitatory). Our decisions were (1)
to limit total current to 2 mA or less based on skin tolerability
and to use electrodes validated for tDCS; and (2) to limit current
further as required to match electric fields corresponding to
approximately 1 mA in adult (current flow criterion).
POTENTIAL MONTAGE SELECTION
Potential Montage Selection involves a selection of candidate
montage to explore further with computational modeling. This
involves integration of prior clinical trials and modeling; (1)
with the subject specific information, desired clinical outcome,
constraints and current flow criterion (Figure 1).
For our study two candidate montages were explored
leveraging computational models to target the primary motor
cortex (M1): (1) a supraorbital montage (M1/SO); and (2)
a bihemispheric montage using the International 10/20 EEG
System designation (C3/C4). Considering the M1/SO montage,
the cathode would have been placed over the contralesional motor
cortex and anode over the ipsilesional supraorbital region with
the intent to inhibit contralesional effects upon the ipsilesional
cortex. The bihemispheric montage was considered with the
cathode placed over the contralesional cortex to down-regulate
excitability, and the anode positioned to facilitate excitation of the
ipsilesional cortex. An individualized head model was developed
based on the child’s 1 mm3 resolution T1-weighted MRI scans
obtained from a Siemens Trio Scanner with a 12-element head
coil using methods described previously (Datta et al., 2012, 2013;
Marquez et al., 2013).
RESULTS
MODELING
Consistent with previous models in adult and children, use of
two large electrodes produced diffuse current flow between and
under the electrodes (Bikson et al., 2012; Figure 2). The current
flow pattern produced in our subject was, in this sense, broadly
consistent with the typical current flow patterns produced by
the M1/SO and C3/C4 montages used in prior clinical trials.
The peak electric field produced in the regions-of-interest (under
the electrodes) as well as across the entire brain (as using two
pads typically produces peak electric field between electrodes) was
compared for this subject and adapted from prior adult and pedi-
atric models (Table 2). As noted previously, there are large (several
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FIGURE 2 | Current flow predictions during tDCS in individual
pediatric model for the M1-SO and Lateralized Temporal montages.
M1-SO- The center of anode (red) was positioned on the motor strip and
the cathode (black) was positioned over the contraletral supraorbital area.
At 0.7 mA applied current, the peak electric field was 0.23 V/m. C3-C4-
The center of anode (red) was positioned over the left temporal lobe and
the cathode (black) was positioned contralateral to the anode (M-O). At
0.7 mA applied current, the peak electric field was 0.29 V/m. EF plots in
the left, right and top views, are shown respectively (A.1a–c, B.1a–c).
Cross-sectional coronal electric field plots were taken from the center of
the anode (A.1.b1, B.1.b1). Directionality plots were also plotted. The red
corresponds to current flowing inwards, the green corresponds to a net
flow of zero, and the blue corresponds to current flowing outwards
(B.1–B.2).
fold) differences in peak electric fields even among adults (Datta
et al., 2012; Edwards et al., 2013). The peak regional and global
electric fields in our subject were comparable to those in previ-
ously modeled children, which are moderately higher than those
in previously modeled adults (though comparable to the most
sensitive adults). As modeled, application of 0.7 mA in our subject
would produce peak electric field comparable to an average adult
receiving 1.0 mA with a comparable distribution of current flow.
SUBJECT-SPECIFIC DOSE DECISION
Intensity and duration
After all prior experience, constraints, and modeling considera-
tions, it was determined that for this single-session intervention
a current intensity of 0.7 mA for 10 consecutive minutes would
be most appropriate to accomplish the primary purpose of the
pilot—establishing tDCS safety and feasibility in children. The
determination of the model for this child was based on the adult
model. Current flow models in the adult present with a wide range
of variability. For example, the potential exists for (1) paradoxical
stimulation under the cathode (Batsikadze et al., 2013); (2) typical
montages stimulating between the electrodes; and (3) access-
ing deeper structures (Dasilva et al., 2012). The low intensity
decided upon was lower than an adult equivalent of approxi-
mately 1.0 mA. The intent was to prevent “direction flipping”
of stimulation while at the same time to rely on available recent
adult safety data with a concomitant assumption of similarities in
electrophysiology in response to stimulation in the brains of both
an adults and children (Brunoni et al., 2011; Marquez et al., 2013).
Considering the child’s diagnosis of perinatal ischemic stroke, a
challenge exists in attempts to incorporate into our calculations
the lesion location and size as well as the variation in conductivity
(cortex, cerebral spinal fluid) (Datta et al., 2009; Bikson et al.,
2012). Incorporating neuromodulatory tools such as TMS as a
locator for motor hotspots may provide additional knowledge
regarding individual cortical excitability (Gillick et al., 2013).
Montage
Specific to the child with focal hemispheric lesion, a translational
goal of the application of tDCS is to improve motor outcomes
(Schlaug et al., 2008). Cathodal tDCS (M1-SO montage) has
shown significant motor improvements in stroke, and specifically
when coupled with rehabilitation (Nair et al., 2011). In children
with language disorders, application of a similar montage-inferior
frontal gyrus/contralateral SO montage was found to be safe and
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Table 1 | Possible adverse events related to transcranial direct current stimulation (tDCS) and risk mitigation.
Study procedure Anticipated risks Risk mitigation
tDCS Burn- Electrolysis Ensure proper electrode contact with skin
tDCS Stimulation in subjects with reduced sensation Assess sensation, avoid placing electrodes over areas of
decreased sensation
tDCS Stimulation over broken skin, reduced resistance Assess skin integrity, avoid placement of electrodes over
recent shaving, skin defects
tDCS Stimulation over conductive implants Screen appropriately for exclusion criteria of implants
tDCS Stimulation over a tumor which may alter metabolic
activity
Screen appropriately for exclusion criteria of neoplasm.
tDCS Threshold altering pharmacologic agent Physician review of each medical record for determination
of appropriateness for study inclusion.
tDCS Itching, Tingling, Burning Sensation in the area of the
electrodes
Ensure proper contact of surface electrodes with skin.
Maintain current dosage within low-range of researched
dosages. Ensure that electrode sponges are properly san-
itized and that saline solution is appropriately employed.
tDCS Headache Ensure that headband securing electrodes is in proper
placement, yet not to the level of impingement of scalp
area. Maintain current dosage within low range of delivery.
tDCS Pain- Neck, Scalp Ensure that electrodes are in proper contact with skin and
adjust head position as needed for comfort.
tDCS Skin Redness Ensure proper electrode position and proper level of
moisture to even stimulation across the electrode
tDCS Fatigue, Sleepiness Screen for continuous effect at follow-up visit.
tDCS Concentration or Mood changes Evaluate cognitive status through physician examination
and psychometric testing at three time points.
feasible. Although we found higher intensities within a range
of comparable safety using an M1/SO montage (Figure 2), we
decided upon a bihemispheric C3 contralesional cathodal/C4
ipsilesional anodal montage. Considering direct involvement of
both hemispheres, we decided to investigate the safety and feasi-
bility of tDCS intensity/application to the pediatric motor cor-
tex bilaterally through an in-out lateralized pattern of activity
between lesioned and non-lesioned hemispheres. This montage
has been applied in both neurologically involved (e.g., stroke) and
healthy adult populations to investigate enhancement of motor
performance (Bolognini et al., 2011; Lefebvre et al., 2012; Kidgell
et al., 2013b). We decided to maintain electrode sizes used in
conventional (adult) trials (as opposed to “child size” electrodes),
that combined with the use of low-voltage and reduced current
intensity (0.7 mA) should enhance tolerability since current den-
sity at the electrode is low minimizing skin sensation and potential
Table 2 | Electrical field (EF) ranges and peaks, in volts per meter, for each modeled head, by montage.
Montage
M1[A]–SO[C] Lateralized motor C3[A]–C4[C] Modeled sponge size
Child 1 (Normal Anatomy) EF Range (C) 0.11–0.27 0.25–0.37 5×5 sponge pads
EF Range (A) 0.14–0.30 0.26–0.44
EF Peak 0.33 0.44
Child 2 (Normal Anatomy) EF Range (C) 0.08–0.31 0.16–0.40 5×5 sponge pads
EF Range (A) 0.18–0.44 0.19–0.40
EF Peak 0.44 0.40
Child 3 Clinical Hemiparesis EF Range (C) 0.05–0.28 0.05–0.23 5×7 sponge pads
EF Range (A) 0.05–0.33 0.07–0.23
EF Peak 0.33 0.42
Adult 1 (Normal Anatomy) EF Range (C) 0.11–0.30 5×5 sponge pads
EF Range (A) 0.11–0.30
EF Peak 0.36
Adult 2 (Normal Anatomy) EF Range (C) 0.08–0.28 5×5 sponge pads
EF Range (A) 0.07–0.24
EF Peak 0.29
Adult 3 (Normal Anatomy) EF Range (C) 0.04–0.19 0.09–0.18 5×5 sponge pads
EF Range (A) 0.07–0.20 0.05–0.21
EF Peak 0.23 0.21
[A] denotes anode and [C] denotes cathode. Detailed descriptions of montages are contained in the text (Adapted from Kessler et al., 2013).
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irritation. The stimulation was expected to be well tolerated given
the total current (0.7 mA) selected to provide average adult brain
electric fields (at 1.0 mA) and use of an electrode design validated
for even higher intensities (up to 2.0 mA).
The goal of this study was to determine the intensity of stimu-
lation and location of electrodes for this tDCS session in children
with hemiparesis. After this integrative dose design consideration,
including modeling, we determined that for this single-session
intervention a current intensity of 0.7 mA in a bihemispheric
C3 contralesional cathodal/C4 ipsilesional anodal montage for
10 consecutive minutes would be within historic safety limits
based on generated brain electric fields to establish safety in
tDCS application with translated to tolerable use in children. This
bi-hemispheric montage over an M1-S0 montage was chosen to
induce neuromodulation between the two hemispheres, lesioned
and non-lesioned, with the potential to increase neuronal activity
on the lesioned hemisphere and transiently inhibit over-activity
of the nonlesioned hemisphere. The child tolerated this session
well, with a sensation reported of mild, tolerable tingling under
the electrodes within the first minute of stimulation which extin-
guished thereafter. The child reported no discomfort, nor did any
adverse events occur (Gillick et al., in press).
DISCUSSION
The montage and parameters of dose represent a modification of
historical adult methods facing the unknowns of pediatric stroke
lesions and tDCS interventions. In summary, our aim was to
design a tDCS protocol to determine an intervention applicable to
pediatric stroke as there is evidence for efficacy of this application
in adult stroke. We sought to determine this current intensity
and montage allowing us to assess the electric field generation
over the target region of M1. We used computational model-
ing and incorporation of past models to test the variation in
parameters and decided upon those which supported safety and
feasibility.
In progressing through a rational work-flow for montage selec-
tion, including assumptions about disease etiology and trade-offs
in “best” montage design which require informed judgment based
on integration across scientific and clinical tDCS literature we
described our process. First, the study design started with safety
as the primary objective. This requires a balance between mini-
mizing dose (e.g., zero risk at zero dose) with maximizing dose to
make results as relevant as possible for subsequent efficacy trials.
This balance influences all subsequent decisions. Next, based
on an assumption of asymmetric dysfunction we adopted a bi-
cephalic (“lateralized”) approach. Then, though adult trials have
used 2.0 mA, we recognized that clinical neurophysiologic studies
increase non-monotonic dose response with high (2.0 mA) catho-
dal stimulation becoming excitatory. Based on our assumption of
disease etiology and adopting a conservative approach, we elected
to approximate a 1.0 mA adult dose. We also elected a relatively
low duration. However both the intensity and duration deter-
mined were still within a range expected to produce significant
lasting changes in brain excitability. Thereafter, to approximate
electric field produced in adults, we determined it was necessary
to decide which electric fields since the distribution in the brain
is variable (e.g., electric field in target, average electric field, peak
electric field across the brain). Moreover, in doing so we assumed
no specific difference in susceptibility of the pediatric (injured)
brain from adult in regards to safety or efficacy, but erred on
approximating a “low” adult dose (intensity, duration). Finally,
with the above caveats we elected to approximate a montage found
successful in adult trials while recognizing the montage produced
diffuse electrode flow through much of the brain, including deep
brain structures. Reinforcing this approach, modeling predicted
that the pattern of current flow across our subject was comparable
to that in previous studies with adult subjects with no significant
distortion due to the presence of the lesion.
Although this method may not be ideal, i.e., an individual
representation of the optimal electric field generated at a target,
the design of the model for this child attempted to incorporate
the knowledge of tDCS modeling in adults and modify to a brain
in a child with congenital hemiparesis. The models assume that
the damaged brain regions have similar conductivity of cerebral
spinal fluid while the peri-lesional area has the conductivity
of healthy brain (Bijsterbosch et al., 2012). However, increased
precision could incorporate changes in conductivity considering
resultant gliosis or other pathologic processes that accompany
cerebral lesions (Ruohonen and Karhu, 2012; Huang et al., 2014).
True comparability among future pediatric studies can only be
established if each tDCS protocol articulates the rationale behind
its methods, as well as current intensity, electrode size, location
and stimulation duration (Nitsche et al., 2008; Batsikadze et al.,
2013). Assessment of physiologic outcomes, serial applications
and the longitudinal effects in combination with rehabilitation
should include a thorough accounting of safety and dosing
parameters.
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